Today

Agents

Chat

Arena

Discover

More

App

Elevance Health Q2 Adjusted EPS USD 7.45 Vs. IBES Estimate USD 6.21 - ELV News | Rallies

Elevance Health Q2 Adjusted EPS USD 7.45 Vs. IBES Estimate USD 6.21

ELV•2026-07-15

Q2 results and outlook

Jul 15 (Reuters) - Elevance Health Q2 operating revenue was USD 49,800 million.

Q2 EPS: USD 6.71
Q2 adjusted EPS: USD 7.45 versus IBES estimate USD 6.21
Q2 benefit expense ratio: 89.7%
FY EPS outlook: USD 20.1
FY adjusted EPS outlook: USD 27 versus IBES estimate USD 26.9

Related News

PNC FY26 Q2 net income rises 16% to $2.1 billion; revenue climbs 12% to $6.88 billion

PNC•2026-07-15

DigitalOcean plans cash repurchase of up to $500 million 2030 convertible notes

DOCN•2026-07-15

M&T Bank's second-quarter profit lifted by interest income growth

•

2026-07-15

Worthington Steel opens EUR 11 per share tender offer for Kloeckner in delisting push

WS•2026-07-15

Merck hosts virtual HIV investor event Aug. 3 after AIDS 2026 data presentations

MRK•2026-07-15